Trials / Completed
CompletedNCT02191527
Evaluating the Effectiveness of Point-of-care Diagnostic Technologies in MCH Services in Mozambique
Evaluating the Effectiveness of Point-of-care Diagnostic Technologies in MCH Services and Their Impact on Mother and Child Health Outcomes in Cabo Delgado Province, Mozambique
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,673 (actual)
- Sponsor
- Elizabeth Glaser Pediatric AIDS Foundation · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The general goal of the proposed study is to evaluate the cost-effectiveness of POC technologies for diagnosis of syphilis, quantitative analysis for hemoglobin and CD4 counting performed within MCH services to improve maternal and infant health. A prospective, quasi-experimental study will be done in Cabo Delgado province, where health facilities will be randomized in an intervention or comparison arm. Outcomes on maternal and infant health will be measured.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | PIMA® for quantitative analysis of CD4-count | |
| DEVICE | Hemocue® (HemoCue AB, Angelhom, Sweden) for quantitative analysis of hemoglobin | |
| DEVICE | SD Bioline® (Standard Diagnostics Inc., South-Korea) for qualitative analysis of syphilis |
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2014-10-01
- Completion
- 2015-02-01
- First posted
- 2014-07-16
- Last updated
- 2020-07-23
Source: ClinicalTrials.gov record NCT02191527. Inclusion in this directory is not an endorsement.